Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study

BACKGROUND: The incidence of carbapenem-resistant organism (CRO) infections is increasing in children. However, pediatric-specific treatment strategies present unique challenges. Ceftazidime/avibactam is a β-lactam/β-lactamase inhibitor combination, showing adequate efficiency against CRO isolates....

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Haiyang, Zhao, Yongmei, An, Qi, Zhu, Baoling, Cao, Zhe, Lu, Jingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492574/
https://www.ncbi.nlm.nih.gov/pubmed/37692471
http://dx.doi.org/10.2147/IDR.S426326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492574/
https://www.ncbi.nlm.nih.gov/pubmed/37692471
http://dx.doi.org/10.2147/IDR.S426326

Ejemplares similares